<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="211985">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00326924</url>
  </required_header>
  <id_info>
    <org_study_id>2004706-01H</org_study_id>
    <nct_id>NCT00326924</nct_id>
  </id_info>
  <brief_title>Age of Red Blood Cells in Premature Infants Study (ARIPI)</brief_title>
  <official_title>Age of Red Blood Cells in Premature Infants Study (ARIPI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if the age of blood transfused to new borns in the NICU setting has an impact
      on their outcome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1. composite outcome of necrotizing enterocolitis, intraventricular hemorrhage, bronchopulmonary dysplasia and retinopathy of prematurity at 30 and 90-days. 2. mortality</measure>
    <time_frame>2 weeks, 4 weeks, 12 weeks, 90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1. individual rates of NEC, IVH, BPD and ROP at 30 and 90 days. 2. incidence of nosocomial infection 3. length of stay in NICU 4. length of mechanical ventilation</measure>
    <time_frame>2 weeks, 4 weeks, 12 weeks, 90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">377</enrollment>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>Biological</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRBCs that are less than 7 days old are considered 'fresh'.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard PRBCs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRBCs 'stored' as per hospital policy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Transfusion</intervention_name>
    <description>PRBC blood transfusions.</description>
    <arm_group_label>Biological</arm_group_label>
    <arm_group_label>Standard PRBCs</arm_group_label>
    <other_name>non applicable</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  birthweight of less than 1250g

          -  admitted to participating NICU

          -  consent acquired from proxy for the patient

        Exclusion Criteria:

          -  already received one or more transfusions

          -  requirement for an exchange transfusion

          -  will be receiving directed donations

          -  have rare blood types/difficult cross-match

          -  proxy has refused consent

          -  moribund on admission to NICU/expected to die

          -  mitigating child protection issues
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>37 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dean Fergusson, PhD</last_name>
    <role>Study Director</role>
    <affiliation>OHRI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <lastchanged_date>November 2, 2014</lastchanged_date>
  <firstreceived_date>May 15, 2006</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
